Odyssey Ventures is an early-stage growth VC firm founded in 2025 with headquarters in London and an office in San Francisco. The firm invests in deep tech and AI companies from pre-seed through Series B+, operating two platforms: an early-stage vehicle for Europe's pre-seed and seed founders, and a global growth platform for Series B+ companies scaling internationally. The firm's thesis centers on Europe building breakthrough technology while the US scales it globally. Founded by Ali Mitchell (former CEO of Huddle and Partner at EQT Ventures) and Michelle Robson (former Investment Director at AP Ventures), Odyssey backs technical founders in areas including neurotech, synthetic biology, hardware engineering tools, and AI infrastructure. Portfolio companies include MintNeuro (neural interface chips), Flow Engineering (hardware design platform), Handshake (AI training), and General.Bio (programmable biology). The firm maintains an invite-only San Francisco network called GBx with 400+ founders, tech executives, and VCs to support portfolio companies entering the US market.
Profile auto-generated from public sources — details unverified.